Sichuan Goldstone Asia Pharmaceutical Inc

Chart & Performance

D1W1MN

P/E

28.75

P/S

3.00

EPS

0.31

Div Yield, %

0.02%

Shrs. gr., 5y

0.20%

Rev. gr., 5y

4.49%

Revenues

1.21b

-2.69%

Net income

126m

-42.32%

CFO

151m

-53.21%

Dividend

Jun 28, 20240.11 CNY/sh

Earnings

May 23, 2025

Profile

Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, manufacture, and sale of medicines and health products in China and internationally. The company offers various pharmaceutical preparations and APIs; Chinese and western pharmaceutical preparations and raw materials; and tablets, capsules, dietary supplements, vitamin products, OTC products, and prescription drugs. It also trades in various pharmaceutical products, such as Chinese herbal medicine materials, Chinese patent medicines, Chinese herbal pieces, chemical raw materials, pharmaceutical preparations, antibiotic preparations, biochemical drugs, dietary supplements, and toxic drugs for medical use, medical devices, etc.; and sells adult drug products under the Quike brand and children's general medicine products under the Mini-Quike brand name. In addition, the company researches, develops, manufactures, and sells plastic composite pipe and vacuum coating machines. Further, it offers reinforced pipe equipment, such as steel reinforced corrugated pipes, reinforced composite polyethylene pipes, fiberglass reinforced RTP pipes, steel reinforced large diameter pipes, steel reinforced corrugated pipe socket and spigot making machines, abrasion resistant industries pipes, extrusion pipe fittings, and perforated steel reinforced polyethylene composite pipes. Additionally, the company provides vacuum coating equipment, including low-emissivity glass coating lines, reflect glass magnetron sputtering coating lines, magnetron sputtering mirror coating production lines, vacuum sputter systems for automotive car mirrors, ITO/TCO glass coating machines, sputtering metallization machines, optical lens coating machines, roll web metallization machines, and air-to-air solar absorption strip sputtering production line; and smart parking equipment. Sichuan Goldstone Asia Pharmaceutical Inc. was founded in 2001 and is based in Chengdu, China.

URL

http://www.goldstone-group.com/

IPO date

Apr 24, 2015

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	1,209,199 -2.69%	1,242,603 17.95%
Cost of revenue	706,903	824,254
Unusual Expense (Income)
NOPBT	502,297	418,349
NOPBT Margin	41.54%	33.67%
Operating Taxes	56,306	77,493
Tax Rate	11.21%	18.52%
NOPAT	445,991	340,856
Net income	126,200 -42.32%	218,787 229.10%
Dividends	(741)
Dividend yield	0.02%
Proceeds from repurchase of equity
BB yield
Debt
Debt current	110,622	10,055
Long-term debt	5,425	517
Deferred revenue	4,715	3,377
Other long-term liabilities	255	341
Net debt	(531,978)	(550,480)
Cash flow
Cash from operating activities	151,143	323,042
CAPEX	(66,098)
Cash from investing activities	(140,500)
Cash from financing activities	98,575
FCF	134,498	365,967
Balance
Cash	588,258	504,118
Long term investments	59,767	56,933
Excess cash	587,565	498,921
Stockholders' equity	572,789	516,068
Invested Capital	1,969,581	1,700,806
ROIC	24.30%	19.42%
ROCE	19.24%	18.39%
EV
Common stock shares outstanding	407,096	401,744
Price	11.06 -18.74%	13.61 25.32%
Market cap	4,502,480 -17.65%	5,467,734 25.32%
EV	3,994,139	4,946,379
EBITDA	596,711	509,671
EV/EBITDA	6.69	9.71
Interest	672	460
Interest/NOPBT	0.13%	0.11%